Millennium Management
QNRX

Millennium Management’s Quoin Pharmaceuticals QNRX Stock Holding History

Millennium Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$503K Buy
76,247
+1,430
+2% +$13K ﹤0.01% 4766
2025
Q4 		$1.08M Buy
+74,817
New +$1.02M ﹤0.01% 4430

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Millennium Management's QNRX Position: Q1 2026 in Review

Millennium Management increased its Quoin Pharmaceuticals (QNRX) stake by 1.9% in Q1 2026, buying an estimated $13K and bringing the position to 76,247 shares worth $503K. The position accounts for ﹤0.01% of the portfolio, ranked #4766.

Millennium Management first reported a position in QNRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.08M in Q4 2025. 22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • Millennium Management held 76,247 shares of Quoin Pharmaceuticals worth $503K as of Q1 2026.
  • Millennium Management bought 1,430 Quoin Pharmaceuticals shares in Q1 2026, an estimated $13K.
  • Quoin Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4766 holding.
  • Millennium Management first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Millennium Management's Quoin Pharmaceuticals position peaked at $1.08M in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.